Mannan-binding lectin is a determinant of survival in infective endocarditis

Clinical and Experimental Immunology

Volumn 148, Issue 1, 2007, Pages 101-105

  Tran, C T ^a,d   Kjeldsen, K ^a   Haunso S ^a   Hoiby N ^a   Johansen, H K ^a,b   Christiansen, M ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Infective endocarditis; Innate immune system; Mannan binding lectin; Mannan binding lectin deficiency

Indexed keywords

MANNAN BINDING LECTIN;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33847642497     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03324.x     Document Type: Article

References (31)

1. Bishara J, Leibovici L, Gartman-Israel D et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis 2001; 33:1636-43.
2. Pedersen SA, Foghsgaard J, Launbjerg J. [Infectious endocarditis in the county of Frederiksborg, 1990-2000. Clinical findings and prognostic aspects] 2. Ugeskr Laeger 2004; 166:2441-6.
3. Tran CT, Kjeldsen K. Endocarditis at a tertiary hospital: reduced acute mortality but poor long term prognosis. Scand J Infect Dis 2006; 38:664-70.
4. Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med 1989; 169:1733-45.
5. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90:31-5.
6. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21:547-78.
7. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56:630-41.
8. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38:133-49.
9. Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000; 2:305-22.
10. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003; 31:753-7.
11. Garred P, Pressler T, Lanng S et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 2002; 33:201-7.
12. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004; 199:1295-9.
13. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188:1394-403.
14. Lipscombe RJ, Sumiya M, Hill AV et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992; 1:709-15.
15. Locht H, Christiansen M, Laursen I. Reactive arthritis and serum levels of mannose binding lectin - lack of association. Clin Exp Immunol 2003; 131:169-73.
16. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 2002; 169:4430-6.
17. Shi L, Takahashi K, Dundee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus 2. J Exp Med 2004; 199:1379-90.
18. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68:688-93.
19. Kars M, van Dijk H, Salimans MM, Bartelink AK, van de Wiel A. Association of furunculosis and familial deficiency of mannose-binding lectin. Eur J Clin Invest 2005; 35:531-4.
20. Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999; 353:1049-53.
21. Moller-Kristensen M, Ip WK, Shi L et al. Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol 2006; 176:1769-75.
22. Graudal NA, Madsen HO, Tarp U et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000; 43:515-21.
23. Heggelund L, Mollnes TE, Espevik T et al. Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection. Eur J Clin Invest 2005; 35:765-70.
24. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 2004; 30:1438-45.
25. Bergmann OJ, Christiansen M, Laursen I et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acutemyeloid leukaemia during remission induction therapy. Eur J Haematol 2003; 70:91-7.
26. Rugonfalvi-Kiss S, Endresz V, Madsen HO et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002; 106:1071-6.
27. Danesh J, Whincup P, Walker M. Chlamydia pneumoniae IgA titres and coronary heart diseaseL prospective study and meta-analysis. Eur Heart J 2003; 24:881.
28. Erlebacher A, Zhang D, Parlow AF, Glimcher LH. Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system. J Clin Invest 2004; 114:39-48.
29. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199:1391-9.
30. Ip WK, To YF, Cheng SK, Lau YL. Serum mannose-binding lectin levels and mbl2 gene polymorphisms in different age and gender groups of southern Chinese adults. Scand J Immunol 2004; 59:310-4.
31. Valdimarsson H, Vikingsdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59:97-102.